PE20020955A1 - Dosificacion metronomica de taxanos - Google Patents

Dosificacion metronomica de taxanos

Info

Publication number
PE20020955A1
PE20020955A1 PE2002000165A PE2002000165A PE20020955A1 PE 20020955 A1 PE20020955 A1 PE 20020955A1 PE 2002000165 A PE2002000165 A PE 2002000165A PE 2002000165 A PE2002000165 A PE 2002000165A PE 20020955 A1 PE20020955 A1 PE 20020955A1
Authority
PE
Peru
Prior art keywords
metronomic
dosage
ter
refers
inhibit tumor
Prior art date
Application number
PE2002000165A
Other languages
English (en)
Spanish (es)
Inventor
Joseph Fargnoli
William C Rose
Pamela A Trail
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20020955A1 publication Critical patent/PE20020955A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
PE2002000165A 2001-02-28 2002-02-27 Dosificacion metronomica de taxanos PE20020955A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28

Publications (1)

Publication Number Publication Date
PE20020955A1 true PE20020955A1 (es) 2002-10-30

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000165A PE20020955A1 (es) 2001-02-28 2002-02-27 Dosificacion metronomica de taxanos

Country Status (31)

Country Link
EP (1) EP1372636B1 (https=)
JP (1) JP2004538253A (https=)
KR (1) KR20030086276A (https=)
CN (1) CN1533273A (https=)
AR (1) AR033609A1 (https=)
AT (1) ATE331511T1 (https=)
BG (1) BG108167A (https=)
BR (1) BR0207519A (https=)
CA (1) CA2439299A1 (https=)
CY (1) CY1105468T1 (https=)
CZ (1) CZ20032232A3 (https=)
DE (2) DE60212813T2 (https=)
DK (1) DK1372636T3 (https=)
EE (1) EE200300413A (https=)
ES (1) ES2211374T3 (https=)
HR (1) HRP20030775A2 (https=)
HU (1) HUP0402115A2 (https=)
IL (1) IL157356A0 (https=)
IS (1) IS6924A (https=)
MX (1) MXPA03007655A (https=)
NO (1) NO20033809L (https=)
PE (1) PE20020955A1 (https=)
PL (1) PL373376A1 (https=)
PT (1) PT1372636E (https=)
RU (1) RU2003129233A (https=)
SK (1) SK10332003A3 (https=)
TR (1) TR200400375T3 (https=)
UY (1) UY27185A1 (https=)
WO (1) WO2002067928A2 (https=)
YU (1) YU66603A (https=)
ZA (1) ZA200306450B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
PL2286794T3 (pl) * 2003-10-15 2016-10-31 Zastosowanie kationowych liposomów zawierających paklitaksel
JP5700909B2 (ja) * 2005-05-04 2015-04-15 メディゲーネ アクチエンゲゼルシャフトMediGene AG パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
DK1372636T3 (da) 2006-11-06
NO20033809D0 (no) 2003-08-27
SK10332003A3 (sk) 2005-03-04
ES2211374T1 (es) 2004-07-16
CA2439299A1 (en) 2002-09-06
CZ20032232A3 (en) 2004-06-16
BG108167A (en) 2004-09-30
JP2004538253A (ja) 2004-12-24
IL157356A0 (en) 2004-02-19
ZA200306450B (en) 2004-11-19
DE60212813D1 (de) 2006-08-10
DE02723255T1 (de) 2004-07-15
WO2002067928A2 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
EP1372636A2 (en) 2004-01-02
AR033609A1 (es) 2003-12-26
IS6924A (is) 2003-08-22
ATE331511T1 (de) 2006-07-15
YU66603A (sh) 2006-08-17
UY27185A1 (es) 2002-09-30
ES2211374T3 (es) 2007-03-01
KR20030086276A (ko) 2003-11-07
CN1533273A (zh) 2004-09-29
RU2003129233A (ru) 2005-02-10
EP1372636B1 (en) 2006-06-28
PT1372636E (pt) 2006-09-29
NO20033809L (no) 2003-10-23
CY1105468T1 (el) 2010-04-28
PL373376A1 (en) 2005-08-22
BR0207519A (pt) 2005-03-08
HRP20030775A2 (en) 2005-02-28
MXPA03007655A (es) 2003-12-04
DE60212813T2 (de) 2007-01-18
HUP0402115A2 (hu) 2005-02-28
EE200300413A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
CR7575A (es) Uso de docetaxel/doxorrubicina/ciclofosfamida en la terapia adyuvante de cancer de mama y ovario
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
CY1111458T1 (el) Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης
ATE341550T1 (de) Quinolinyl-pyrrolopyrazole
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
NO20070580L (no) Behandling av cancer.
CY1113533T1 (el) Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης
BR0207443A (pt) Método e forma de dosagem para o tratamento de tumores pela administração de tegafur, uracila, ácido folìnico, paclitaxel e carboplatina
AR025885A1 (es) Derivados del acido indolil-3-glioxilico con valiosas propiedades terapeuticas
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
ITMI20022777A1 (it) Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
PE20020955A1 (es) Dosificacion metronomica de taxanos
DE60019947D1 (de) Vorbeugung von kolorektalkrebs
MX2023014898A (es) Terapia combinada anti-vhc ventajosa.
AR052152A1 (es) Producto farmaceutico para el tratamiento preventivo y terapeutico de trastornos del sueno
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
NO20061284L (no) Terapeutiske regimer for admistrasjon av legemiddelkombinasjoner
CL2004000767A1 (es) Unidad de dosificacion oral que comprende un agente antagonista de bombas de protones y excipientes de caracter basico; procedimiento para su preparacion, utiles para tratar enfermedades causadas por una secrecion aumentada de acidos gastricos.
ATE551999T1 (de) P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff
SE0203817D0 (sv) New composition
DK1565176T3 (da) Middel med ödelæggende virkning på maligne rumorer samt fremgangsmåde til fremstilling heraf
AR048068A1 (es) Piperazinas derivadas de urea para el tratamiento de endometriosis
RU2003115034A (ru) Способ одновременного моделирования хронического панкреатита и гепатита

Legal Events

Date Code Title Description
FA Abandonment or withdrawal